课题基金 / 基金详情

项目摘要

项目成果

Wendy L Picking的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):福氏志贺菌引起细菌性痢疾的能力需要使用III型分泌系统(TTSS),该系统将转运蛋白IpaB和IpaC递送至宿主细胞膜,以产生用于将效应蛋白转运至宿主细胞质中的孔。最终结果是病原体侵入靶细胞。iPad控制转运蛋白从TTSS针尖的位置分泌和递送至宿主膜。iPad无效突变体组成型分泌IpaB和IpaC,并且不能侵入哺乳动物细胞。在同一方面,iPad内的缺失阻止其与TTSS针尖的稳定结合,导致分泌控制和侵袭性的丧失,证明了iPad在针尖定位的重要性。向志贺氏菌生长培养基中添加胆汁盐以iPad依赖性方式促进IpaB向针尖的募集。这是第一次证明转运蛋白与TTSS针稳定相关。因此,我们假设iPad感知环境信号,触发IpaB的动员针尖作为分泌成熟的最后一步。为了验证这一假设,本研究的具体目的是:1)确定iPad环境传感的分子基础; 2)确定胆盐效应的生化和结构基础。本研究的第一个目的将围绕基于iPad晶体结构的胆盐效应的诱变研究,以确定特定结构域在感测胆盐和触发IpaB动员中的作用。第二个目标将需要化学合成的荧光胆汁盐,将用于荧光光谱研究,以评估胆盐与iPad和突变iPad蛋白的相互作用。 TTSS针尖蛋白的存在似乎是TTSS中的共同特征。由于这些分泌系统是许多革兰氏阴性病原体的关键毒力因子,因此定义尖端蛋白质用于控制转位子形成的第一步的机制应有助于设计用于预防这些病原体感染的新化合物,并确定疫苗开发的新靶点。 本研究探讨了胆汁盐与福氏志贺菌表面感觉蛋白的相互作用,这些感觉蛋白控制着毒力蛋白向人肠道细胞的传递。因为III型分泌蛋白在革兰氏阴性病原体中是保守的,所以这项工作的完成将对理解不同革兰氏阴性细菌病原体的发病机制和确定这些细菌的发病机制可以被阻断的步骤具有长期影响。
英文摘要
DESCRIPTION (provided by applicant): The ability for Shigella flexneri to cause bacillary dysentery requires the use of a type III secretion system (TTSS) that delivers the translocator proteins IpaB and IpaC to host cell membranes to create a pore for the transport of effector proteins into the host cytoplasm. The net result is pathogen invasion of the target cell. IpaD controls the secretion and delivery of the translocator proteins to the host membrane from a position at the tip of the TTSS needle. ipaD null mutants constitutively secrete IpaB and IpaC and cannot invade mammalian cells. In the same respect, deletions within IpaD that prevent its stable association with the TTSS needle tip result in a loss of secretion control and invasiveness, demonstrating the importance of IpaD localization at the needle tip. The addition of bile salts to the Shigella growth medium promotes the recruitment of IpaB to the needle tip in an IpaD dependent manner. This is the first demonstration of a translocator protein stably associating with the TTSS needle. We thus hypothesize that IpaD senses environmental signals to trigger the mobilization of IpaB to the needle tip as the final step in secreton maturation. To test this hypothesis, the specific aims of this investigation are: 1) determine the molecular basis for environmental sensing by IpaD; and 2) determine the biochemical and structural basis for the effects of bile salts. The first aim of this investigation will center around a mutagenesis study of bile salt effects based on the crystal structure of IpaD to determine the roles of specific domains in sensing bile salts and triggering IpaB mobilization. The second aim will require the chemical synthesis of fluorescent bile salts that will be used in fluorescence spectroscopy studies to assess bile salt interactions with IpaD and mutant IpaD proteins. The presence of TTSS needle tip proteins appears to be a common feature among TTSSs. Because these secretions systems are key virulence factors for many gram-negative pathogens, defining the mechanism used by the tip proteins to control the first steps in translocon formation should help in designing new compounds for preventing infections by these pathogens and identifying new targets for vaccine development. This investigation explores the interaction of bile salts with sensory proteins on the surface of Shigella flexneri that control the delivery of virulence proteins to human intestinal cells. Because the type III secretion proteins targeted here are conserved among a broad range of gram-negative pathogens, completion of this work will have long term implications in understanding the pathogenesis of diverse gram-negative bacterial pathogens and in identifying steps at which the pathogenesis of these bacteria can be blocked.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
An intranasal room stable vaccine formulation to prevent Pseudomonas aeruginosa (R21AI169691)
  • 批准号:
    10741018
  • 项目类别:
  • 资助金额:
    $22.97万
  • 财政年份:
    2023
  • 负责人:
    Wendy L Picking
  • 依托单位:
Resources and Workforce Development for Research on NIH/NIAID High Priority Pathogens at the University of Missouri Regional Biocontainment Laboratory
  • 批准号:
    10793827
  • 项目类别:
  • 资助金额:
    $259.55万
  • 财政年份:
    2023
  • 负责人:
    Wendy L Picking
  • 依托单位:
A prophylactic vaccine to prevent colonization by Pseudomonas aeruginosa
  • 批准号:
    10582221
  • 项目类别:
  • 资助金额:
    $80.07万
  • 财政年份:
    2022
  • 负责人:
    Wendy L Picking
  • 依托单位:
A vaccine specifically targeting T3SS-negative Pseudomonas aeruginosa
  • 批准号:
    10636201
  • 项目类别:
  • 资助金额:
    $19.56万
  • 财政年份:
    2021
  • 负责人:
    Wendy L Picking
  • 依托单位:
海外基金